A new drug being trialled for treating breast cancer and diabetes has been shown to ‘melt away’ the fat inside arteries that can cause heart attacks and strokes.
Researchers from the University of Aberdeen, using pre-clinical mouse models, showed that just a single dose of the drug (Trodusquemine) completely reversed the effects of a disease that causes a host of heart problems.
Atherosclerosis is the build-up of fatty material inside the arteries.
Over time this fatty material can grow bigger until your arteries become so narrow that not enough blood can pass through.
Atherosclerosis is the condition that causes most heart attacks and strokes.
In pre-clinical tests, mice with set-in atherosclerosis, mimicking what happens in humans, had less fatty plaques in their arteries whether they had regular doses over time or just a single dose of Trodusquemine.
The drug works by stopping an enzyme called PTP1B, which is normally increased in people with obesity or diabetes and conditions involving prolonged inflammation such as sepsis, inflamed diabetic foot ulcers and allergic lung inflammation. The researchers found that it also stimulated the action of another protein (AMPK), which effectively mimics exercise and reduces chronic inflammation.
It has already been shown to be effective with diabetes and breast cancer patients but this is the first time the drug has been shown to have benefits for long-term cardiovascular disease.
The £236,000 study was funded by the British Heart Foundation.
Professor Mirela Delibegovic and Dr Dawn Thompson from the University of Aberdeen’s Institute of Medical Sciences who led the study said: “All humans have some level of atherosclerosis. As you age you start to develop these fatty streaks inside your arteries. It is a big problem for people who are overweight or have underlying cardiovascular conditions.”
“Trodusquemine has already been trialled for treatment of diabetes and breast cancer but this is the first time it has been used in models of atherosclerosis.
“These have only been tested at pre-clinical level, in mice, so far but the results were quite impressive and showed that just a single dose of this drug seemed to completely reverse the effects of arthrosclerosis.
“The next step is to test the ability of this drug to improve outcomes in human patients with developed atherosclerosis and cardiovascular disease”.
Learn more: Drug ‘melts away’ fat inside arteries
The Latest on: Atherosclerosis
- Critical Limb Ischemia Treatment Market: Rise in Prevalence of Critical Limb Ischemia to Drive the Market on May 20, 2019 at 6:46 am
Critical limb ischemia (CLI) is a severe peripheral arterial disease (PAD), wherein chronic inflammation associated with atherosclerosis (progressive thickening of arteries lining) causes reduced ... […]
- Time-resolved small-angle neutron scattering as a probe for the dynamics of lipid exchange between human lipoproteins and naturally derived membranes on May 20, 2019 at 2:45 am
Atherosclerosis is the main killer in the western world. Today’s clinical markers include the total level of cholesterol and high-/low-density lipoproteins, which often fails to accurately predict the ... […]
- Elucid Bioimaging Announces Notice of Award on May 17, 2019 at 5:00 pm
May 17, 2019 /PRNewswire-PRWeb/ -- Elucid Bioimaging, Inc. today announced that that it has been awarded a highly-competitive Phase IIB Bridge Award from the National Heart, Lung, and Blood Institute ... […]
- Arterial Stents Market to Double During 2017-2025, Rise in Cardiovascular Diseases to Support Growth on May 17, 2019 at 8:24 am
The global arterial stents market is rising due to the increasing prevalence of atherosclerosis and other arterial disorders along with introduction of innovative arterial stents such as bioresorbable ... […]
- Study finds higher risk of stroke-linked plaque in men, possible test for women on May 16, 2019 at 9:36 am
Carotid atherosclerosis causes at least 15% to 20% of ischemic strokes, the most common type of stroke in which blood flow to the brain has been blocked. Unstable plaques in the neck arteries are ... […]
- HDL Therapeutics Announces Positive Data From Registration Trial of PDS-2™ System in Homozygous Familial Hypercholesterolemia on May 15, 2019 at 2:45 pm
May 15, 2019 /PRNewswire/ -- HDL Therapeutics, a clinical stage company and an emerging leader in the field of reversing coronary atherosclerosis, today announced positive data from the company's ... […]
- Bladder drug linked to atherosclerosis in mice on May 14, 2019 at 4:23 am
A drug used in the treatment of overactive bladder can accelerate atherosclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the ... […]
- Managing clogged arteries (atherosclerosis) on May 11, 2019 at 8:34 pm
Arteries supply blood from the heart to other parts of the body. According to experts, when arteries are in good condition, they allow the flow of oxygen-rich blood throughout the body, but ... […]
- The Link between Hematopoiesis and Atherosclerosis on May 8, 2019 at 2:12 pm
The authorized source of trusted medical research and education for the Chinese-language medical community. The New England Journal of Medicine The most trusted, influential source of new medical ... […]
- Atherosclerosis: Induced cell death destabilizes plaques on May 1, 2019 at 1:30 pm
Many chronic disorders arise from misdirected immune responses. Scientists now show that neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death and that a tailored peptide ... […]
via Google News and Bing News